4.5 Article

Evaluation of electroencephalography biomarkers for Angelman syndrome during overnight sleep

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Quantitative EEG Analysis in Angelman Syndrome: Candidate Method for Assessing Therapeutics

Luis A. Martinez et al.

Summary: The goal of these studies was to use quantitative EEG techniques to evaluate the potential of spectral power analysis as a biomarker and quantitative method for evaluating therapeutics in children with Angelman syndrome. The findings suggest that qEEG analysis can be useful in evaluating Angelman syndrome and assessing therapeutic efficacy.

CLINICAL EEG AND NEUROSCIENCE (2023)

Article Biochemistry & Molecular Biology

Angelman syndrome genotypes manifest varying degrees of clinical severity and developmental impairment

Marius Keute et al.

Summary: The study found that different genetic subtypes of Angelman Syndrome present with different clinical severity, with individuals with UBE3A pathogenic variants and imprinting defects being less affected, while those with uniparental paternal disomy are more severely affected. Individuals with truncating mutations in UBE3A are more impaired than those with missense mutations. Genomic regions beyond UBE3A also contribute to the AS phenotype.

MOLECULAR PSYCHIATRY (2021)

Review Clinical Neurology

UBE3A reinstatement as a disease-modifying therapy for Angelman syndrome

Ype Elgersma et al.

Summary: Angelman syndrome, caused by mutations in the maternally inherited UBE3A gene, remains a rare disease without effective treatments. Strategies targeting critical substrates of UBE3A and restoring UBE3A protein levels are highly anticipated for disease modification.

DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2021)

Article Medicine, Research & Experimental

CRISPR/Cas9 directed to the Ube3a antisense transcript improves Angelman syndrome phenotype in mice

Ralf S. Schmid et al.

Summary: Gene editing technology shows potential in treating Angelman syndrome in a mouse model by partially correcting behavioral phenotypes. This therapeutic approach aims to unsilence the paternal gene in neurons, providing lasting therapeutic effects for patients with AS.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Article Genetics & Heredity

Abnormal electrophysiological phenotypes and sleep deficits in a mouse model of Angelman Syndrome

N. A. Copping et al.

Summary: Our study focused on translational neurophysiological outcomes in an Angelman Syndrome (AS) model. We found that Ube3a-del mice have a reduced seizure threshold and increased epileptiform spiking activity and delta power in EEG compared to WT. Additionally, Ube3a-del mice show less time in both paradoxical and slow-wave sleep, longer latencies to paradoxical sleep stages, and fewer sleep spindles, which are critical for memory consolidation.

MOLECULAR AUTISM (2021)

Article Neurosciences

Early Developmental EEG and Seizure Phenotypes in a Full Gene Deletion of Ubiquitin Protein Ligase E3A Rat Model of Angelman Syndrome

Heather A. Born et al.

Summary: The maternal deletion of Ube3a in rats was found to result in epileptiform activity and significantly increased delta power in EEG, confirming the validity of this model in replicating some clinical aspects of Angelman syndrome.

ENEURO (2021)

Article Biology

An open-source, high-performance tool for automated sleep staging

Raphael Vallat et al.

Summary: The clinical and societal measurement of human sleep has increased significantly in recent years, however, basic and clinical sleep research still relies on human visual scoring. A novel algorithm is described in this paper, which offers high sleep-staging accuracy across different populations around the world.

ELIFE (2021)

Review Physiology

Changes in sleep EEG with aging in humans and rodents

Diana Campos-Beltran et al.

Summary: Sleep is a ubiquitous yet complex animal behavior, regulated by circadian and homeostatic processes. Sleep patterns vary between species, characterized by brain electric activity and electromyography patterns. Research indicates links between sleep and aging, requiring a more integrated view to explain these connections.

PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2021)

Review Pharmacology & Pharmacy

Therapies in preclinical and clinical development for Angelman syndrome

Theodora Markati et al.

Summary: This review discusses the current therapeutic approaches for Angelman syndrome, including gene and enzyme replacement therapies, targeting non-coding RNA, and compounds targeting molecular pathways. The future of Angelman syndrome treatment looks promising with potentially more than five disease-modifying treatments at clinical testing by 2022-2023, but challenges such as safety and efficacy need to be addressed, along with a need for improved clinical trial readiness.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2021)

Article Genetics & Heredity

Abnormal sleep physiology in children with 15q11.2-13.1 duplication (Dup15q) syndrome

Vidya Saravanapandian et al.

Summary: Children with Dup15q syndrome exhibit abnormal sleep physiology with increased beta power, reduced spindle density, and reduced or absent slow-wave sleep compared to age-matched neurotypical controls. This genetic condition highly penetrant for ASD shows three quantitative EEG biomarkers of sleep disruption, providing insights for further studies on the association between sleep and cognition.

MOLECULAR AUTISM (2021)

Article Clinical Neurology

Delta power robustly predicts cognitive function in Angelman syndrome

Lauren M. Ostrowski et al.

Summary: Through analyzing EEG recordings and cognitive assessments in individuals with AS, it was found that delta power serves as a reliable biomarker for cognitive function; Delta power can predict Bayley Cognitive Scores with high accuracy and robustness; This electrophysiological biomarker offers an objective and clinically relevant endpoint for treatment response in clinical trials.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2021)

Article Medicine, Research & Experimental

Antisense oligonucleotide treatment rescues UBE3A expression and multiple phenotypes of an Angelman syndrome mouse model

Claudia Milazzo et al.

Summary: Research findings demonstrate that ASO-induced reactivation of UBE3A in AS mice can lead to positive effects on AS phenotypes, such as restored sensitivity to seizures and improvements in behavior, indicating therapeutic potential.

JCI INSIGHT (2021)

Article Neurosciences

Electrophysiological Abnormalities in Angelman Syndrome Correlate With Symptom Severity

Joerg F. Hipp et al.

Summary: The study found a relationship between EEG abnormalities and symptom severity in AS, highlighting the importance of EEG in the pathophysiology of AS. By analyzing spatial and spectral information of EEG, a more accurate assessment of clinical severity in AS patients can be achieved.

BIOLOGICAL PSYCHIATRY: GLOBAL OPEN SCIENCE (2021)

Article Clinical Neurology

Association of sleep spindle activity and sleepiness in children with sleep-disordered breathing

Pablo E. Brockmann et al.

JOURNAL OF CLINICAL SLEEP MEDICINE (2020)

Review Clinical Neurology

Sleep EEG oscillations in neurodevelopmental disorders without intellectual disabilities

Maurizio Gorgoni et al.

SLEEP MEDICINE REVIEWS (2020)

Article Multidisciplinary Sciences

Cas9 gene therapy for Angelman syndrome trapsUbe3a-ATSlong non-coding RNA

Justin M. Wolter et al.

NATURE (2020)

Article Psychology, Biological

High-voltage, diffuse delta rhythms coincide with wakeful consciousness and complexity in Angelman syndrome

Joel Frohlich et al.

NEUROSCIENCE OF CONSCIOUSNESS (2020)

Article Biochemical Research Methods

A sleep spindle detection algorithm that emulates human expert spindle scoring

Karine Lacourse et al.

JOURNAL OF NEUROSCIENCE METHODS (2019)

Article Neurosciences

Electrophysiological Phenotype in Angelman Syndrome Differs Between Genotypes

Joel Frohlich et al.

BIOLOGICAL PSYCHIATRY (2019)

Article Clinical Neurology

Sleep spindle activity in children with obstructive sleep apnea as a marker of neurocognitive performance: A pilot study

Pablo E. Brockmann et al.

EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2018)

Article Clinical Neurology

Delta rhythmicity is a reliable EEG biomarker in Angelman syndrome: a parallel mouse and human analysis

Michael S. Sidorov et al.

JOURNAL OF NEURODEVELOPMENTAL DISORDERS (2017)

Review Genetics & Heredity

Unmet clinical needs and burden in Angelman syndrome: a review of the literature

Anne C. Wheeler et al.

ORPHANET JOURNAL OF RARE DISEASES (2017)

Article Multidisciplinary Sciences

Strain-dependence of the Angelman Syndrome phenotypes in Ube3a maternal deficiency mice

Heather A. Born et al.

SCIENTIFIC REPORTS (2017)

Review Neurosciences

Sleep Spindles as Facilitators of Memory Formation and Learning

Daniel Ulrich

NEURAL PLASTICITY (2016)

Review Clinical Neurology

Electrophysiological biomarkers of diagnosis and outcome in neurodevelopmental disorders

Shafali S. Jeste et al.

CURRENT OPINION IN NEUROLOGY (2015)

Article Clinical Neurology

Characterization of Topographically Specific Sleep Spindles in Mice

Dongwook Kim et al.

SLEEP (2015)

Article Clinical Neurology

Characterization of Topographically Specific Sleep Spindles in Mice

Dongwook Kim et al.

SLEEP (2015)

Article Multidisciplinary Sciences

Towards a therapy for Angelman syndrome by targeting a long non-coding RNA

Linyan Meng et al.

NATURE (2015)

Review Genetics & Heredity

Angelman syndrome: review of clinical and molecular aspects

Lynne M. Bird

APPLICATION OF CLINICAL GENETICS (2014)

Review Clinical Neurology

Neurologic Manifestations of Angelman Syndrome

Ronald L. Thibert et al.

PEDIATRIC NEUROLOGY (2013)

Review Clinical Neurology

Resting state EEG abnormalities in autism spectrum disorders

Jun Wang et al.

JOURNAL OF NEURODEVELOPMENTAL DISORDERS (2013)

Article Behavioral Sciences

Analysis of EEG patterns and genotypes in patients with Angelman syndrome

Martina Vendrame et al.

EPILEPSY & BEHAVIOR (2012)

Article Biochemistry & Molecular Biology

Ube3a-ATS is an atypical RNA polymerase II transcript that represses the paternal expression of Ube3a

Linyan Meng et al.

HUMAN MOLECULAR GENETICS (2012)

Article Multidisciplinary Sciences

Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons

Hsien-Sung Huang et al.

NATURE (2012)

Article Neurosciences

Sleep Spindles in Humans: Insights from Intracranial EEG and Unit Recordings

Thomas Andrillon et al.

JOURNAL OF NEUROSCIENCE (2011)

Article Medicine, General & Internal

Normal human sleep: an overview

M Hirshkowitz

MEDICAL CLINICS OF NORTH AMERICA (2004)

Article Clinical Neurology

Sleep polygraphy in Angelman syndrome

S Miano et al.

CLINICAL NEUROPHYSIOLOGY (2004)